The use of drones in medical emergency response is moving into a new phase of commercial expansion after Swedish company Everdrone raised SEK 36 million — roughly €3.1 million — in fresh funding. The investment is intended to help validate the integration of autonomous drone systems into healthcare services and accelerate the company’s entry into additional European markets.

The development matters because it signals a broader shift in how emergency care may be delivered in the coming years. Rather than being treated as experimental technology, medical drones are increasingly being positioned as practical infrastructure for faster intervention in life-threatening situations.

Everdrone develops autonomous drones for urgent medical response, enabling the rapid delivery of equipment such as defibrillators before ambulances arrive on site. The value proposition is simple but powerful: in critical cases such as cardiac arrest, every minute matters, and reducing response time can mean the difference between life and death.

That is what makes this market so significant. Healthcare systems across Europe are under pressure to improve coverage, reduce delays and extend emergency response capacity across both densely populated cities and more remote areas. In that context, drone-based delivery is emerging not as a futuristic concept, but as a realistic operational tool.

Everdrone is already active in Västra Götaland, Sweden, where it operates what it describes as the first drone service fully integrated into a real medical emergency response chain. Its technology is also being adopted in other regions, including Stockholm and Normandy, France, suggesting that the model is beginning to move beyond a single pilot environment into broader institutional use.

“This funding puts us in a stronger position to continue building the company and expanding our services into more European markets,” said Mats Sällström, CEO of Everdrone. He also pointed to the growing demand for solutions that can help healthcare systems reduce response times and improve access to urgent care.

The funding round was led by Sciety, an investor focused on health and digital technologies. For the fund, the attraction is clear: Everdrone is not addressing a speculative use case, but a pressing and measurable problem in emergency medicine.

“Everdrone addresses a clear need in medical emergency response and has already established partnerships with several regions in Sweden and France,” said Andreas Lindblom, Managing Partner at Sciety.

Since its founding, the company has developed its technology in close collaboration with healthcare stakeholders and has been conducting real-world operations since 2020. That track record matters. In health technology, credibility is built not only on engineering, but on proven integration into actual care systems.

What this latest round really signals is that emergency drones may be entering a more mature chapter. The question is no longer whether the technology works in isolated test cases, but whether it can be deployed at scale, integrated into public health systems, and adopted across borders.

If that happens, companies like Everdrone could help redefine part of Europe’s emergency response infrastructure — and show how autonomous technology can move from innovation story to life-saving public service.